Xle Disease In Blood

Cure Arthritis Naturally

Cure Arthritis Naturally

Get Instant Access

39. Brady K, Corash L, Bhargava V: Multiple myeloma arising from monoclonal gammopathy of undetermined significance in a patient with Gaucher's disease. Arch Pathol Lab Med 121:1108-1111, 1997.

40. Shoenfeld Y, Gallant LA, Shaklai M, Livni E, Djaldetti M, Pinkhas J: Gaucher's disease: a disease with chronic stimulation of the immune system. Arch Pathol Lab Med 106:388-391, 1982.

41. Brautbar A, Elstein D, Pines G, Abrahamov A, Zimran A: Effect of enzyme replacement therapy on gammopathies in Gaucher disease. Blood Cells Mol Dis 32:214-217, 2004.

42. Toth J, Kiss T, Varga S: [Multiple myeloma associated with rheumatoid arthritis]. Orv Hetil 113:2414-2415, 1972.

43. Perl AF: Multiple myeloma simulating rheumatoid arthritis. Can Med Assoc J 79:122-123, 1958.

44. Davis JS Jr, Weber FC, Bartfeld H: Conditions involving the hemopoietic system resulting in a pseudorheumatoid arthritis; similarity of multiple myeloma and rheumatoid arthritis. Ann Intern Med 47:10-17, 1957.

45. Buskila D, Sukenik S: [Multiple myeloma complicating rheumatoid arthritis]. Harefuah 115:319-321, 1988.

46. Hamano T, Ishikawa T, Yabe H, Nagai K, Nakayama S: [Rheumatoid arthritis terminating in multiple myeloma-a case report]. Rinsho Ketsueki 28:408-412, 1987.

47. Matsumori A, Nishiya K, Chijiwa T, et al.: [Two cases of rheumatoid arthritis associated with IgA-type multiple myeloma]. Ryumachi 40:26-31, 2000.

48. Usnarska-Zubkiewicz L, Czarnecka M, Wlodarczyk S, Nowak E: [Rheumatoid arthritis as a risk factor for development of multiple myeloma]. Pol Arch Med Wewn 97:253-259, 1997.

49. Eriksson M. Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer 29A:259-263, 1993.

50. Rettig MB, Ma HJ, Vescio RA, et al.: Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 276:1851-1854, 1997.

51. Tisdale JF, Stewart AK, Dickstein B, et al.: Molecular and serological examination of the relationship of human herpesvirus 8 to multiple myeloma: orf 26 sequences in bone marrow stroma are not restricted to myeloma patients and other regions of the genome are not detected. Blood 92:2681-2687, 1998.

52. Patel M, Mahlangu J, Patel J, et al.: Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and multiple myeloma in South Africa. Diagn Mol Pathol 10: 95-99, 2001.

53. Bouscary D, Dupin N, Fichelson S, et al.: Lack of evidence of an association between HHV-8 and multiple myeloma. Leukemia 12:1840-1841, 1998.

54. Rask C, Kelsen J, Olesen G, Nielsen JL, Obel N, Abildgaard N: Danish patients with untreated multiple myeloma do not harbour human herpesvirus 8. Br J Haematol 108:96-98, 2000.

55. MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF: HHV-8 and multiple myeloma in the UK. Lancet 350:1144-1145, 1997.

56. Marcelin AG, Dupin N, Bouscary D, et al.: HHV-8 and multiple myeloma in France. Lancet 350:1144, 1997.

57. Cannon MJ, Flanders WD, Pellett PE: Occurrence of primary cancers in association with multiple myeloma and Kaposi's sarcoma in the United States, 1973-1995. Int J Cancer 85:453-456, 2000.

58. Voelkerding KV, Sandhaus LM, Kim HC, et al.: Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. Am J Clin Pathol 92:222-228, 1989.

59. Karnad AB, Martin AW, Koh HK, Brauer MJ, Novich M, Wright J: Nonsecretory multiple myeloma in a 26-year-old man with acquired immunodeficiency syndrome, presenting with multiple extramedullary plasmacy-

tomas and osteolytic bone disease. Am J Hematol 32:305-310, 1989.

60. Barbanera M, Menicagli V: [Multiple myeloma in HIV infection]. Recenti Prog Med 81:663-665, 1990.

61. Konrad RJ, Kricka LJ, Goodman DB, Goldman J, Silberstein LE: Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient. N Engl J Med 328:1817-1819, 1993.

62. Kumar S, Kumar D, Schnadig VJ, Selvanayagam P, Slaughter DP: Plasma cell myeloma in patients who are HIV-positive. Am J Clin Pathol 102:633-639, 1994.

63. Yee TT, Murphy K, Johnson M, et al.: Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infection. Am JHematol 66:123-125, 2001.

64. Pouli A, Lemessiou H, Rontogianni D, et al.: Multiple myeloma as the first manifestation of acquired immunodeficiency syndrome: a case report and review of the literature. Ann Hematol 80:557-560, 2001.

65. Lallemand F, Fritsch L, Cywiner-Golenzer C, Rozenbaum W: Multiple myeloma in an HIV-positive man presenting with primary cutaneous plasmacy-tomas and spinal cord compression. J Am Acad Dermatol 39:506-508, 1998.

66. Talib SH, Singh J, Ranga S, Talib VH: Multiple myeloma complicating HIV-infection. A case report. Indian J Pathol Microbiol 40:413-416, 1997.

67. Faure I, Viallard JF, Mercie P, Bonnefoy M, Pellegrin JL, Leng B: Multiple myeloma in two HIV-infected patients. AIDS 13:1797-1799, 1999.

68. Elira Dokekias A, Moutschen M, Purhuence MF, Malanda

F, Moyikoua A: [Multiples's myeloma and HIV infection: report of 3 cases]. Rev Med Liege 59:95-97, 2004.

69. Montella M, Crispo A, Frigeri F, et al.: HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001;25:775-781.

70. Silvestri F, Barillari G, Fanin R, et al.: Risk of hepatitis C virus infection, Waldenstrom's macroglobulinemia, and monoclonal gammopathies. Blood 88:1125-1126, 1996.

71. Gharagozloo S, Khoshnoodi J, Shokri F: Hepatitis C virus infection in patients with essential mixed cryo-globulinemia, multiple myeloma and chronic lympho-cytic leukemia. Pathol Oncol Res 7:135-139, 2001.

72. Rabkin CS, Tess BH, Christianson RE, et al.: Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia. Blood 99:4240-4242, 2002.

73. Bianco E, Marcucci F, Mele A, et al.: Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian multi-center case-control study. Haematologica 89:70-76, 2004.

74. Hausfater P, Cacoub P, Sterkers Y, et al.: Hepatitis C virus infection and lymphoproliferative diseases: prospective study on 1,576 patients in France. Am J Hematol 67:168-171, 2001.

75. Besson C, Gonin C, Brebion A, Delaunay C, Panelatti

G, Plumelle Y: Incidence of hematological malignancies in Martinique, French West Indies, overrepresenta-tion of multiple myeloma and adult T cell leukemia/lymphoma. Leukemia 15:828-831, 2001.

76. Cardis E, Gilbert ES, Carpenter L, et al.: Effects of low doses and low dose rates of external ionizing radiation:

cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117-132, 1995.

77. Douglas AJ, Omar RZ, Smith PG: Cancer mortality and morbidity among workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 70:1232-1243, 1994.

78. Wing S, Richardson D, Wolf S, Mihlan G, Crawford-Brown D, Wood J: A case control study of multiple myeloma at four nuclear facilities. Ann Epidemiol 10:144-153, 2000.

79. Baysson H, Laurier D, Tirmarche M, Valenty M, Giraud JM: Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occup Environ Med 57:188-194, 2000.

80. Lopez-Abente G, Aragones N, Pollan M, Ruiz M, Gandarillas A: Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. Cancer Epidemiol Biomarkers Prev 8:925-934, 1999.

81. Agu VU, Christensen BL, Buffler PA: Geographic patterns of multiple myeloma: racial and industrial correlates, State of Texas, 1969-71. J Natl Cancer Inst 65:735-738, 1980.

82. Burmeister LF: Cancer mortality in Iowa farmers, 1971-78. J Natl Cancer Inst 66:461-464, 1981.

83. Cerhan JR, Cantor KP, Williamson K, Lynch CF, Torner JC, Burmeister LF: Cancer mortality among Iowa farmers: recent results, time trends, and lifestyle factors (United States). Cancer Causes Control 9:311-319, 1998.

84. Blair A: Cancer risks associated with agriculture: epi-demiologic evidence. Basic Life Sci 21:93-111, 1982.

85. Steineck G, Wiklund K: Multiple myeloma in Swedish agricultural workers. Int J Epidemiol 15:321-325, 1986.

86. Khuder SA, Mutgi AB: Meta-analyses of multiple myeloma and farming. Am JInd Med 32:510-516, 1997.

87. Assennato G, Ferri GM, Tria G, Porro A, Macinagrossa L, Ruggieri M: [Tumors of the hemolymphopoietic tract and employment in agriculture: a case-control study carried out in an epidemiologic area in southern Italy]. G Ital Med Lav 17:91-97, 1995.

88. Nanni O, Falcini F, Buiatti E, et al.: Multiple myeloma and work in agriculture: results of a case-control study in Forli, Italy. Cancer Causes Control 9:277-283, 1998.

89. Pukkala E, Notkola V: Cancer incidence among Finnish farmers, 1979-93. Cancer Causes Control 8:25-33, 1997.

90. Pahwa P, McDuffie HH, Dosman JA, et al.: Exposure to animals and selected risk factors among Canadian farm residents with Hodgkin's disease, multiple myeloma, or soft tissue sarcoma. J Occup Environ Med 45:857-868, 2003.

91. Monson RR, Nakano KK: Mortality among rubber workers. II: Other employees. Am J Epidemiol 103: 297-303, 1976.

92. Delzell E, Monson RR: Mortality among rubber workers. X: Reclaim workers. Am J Ind Med 7:307-313, 1985.

93. Matanoski G, Elliott E, Tao X, Francis M, Correa-Villasenor A, Santos-Burgoa C: Lymphohematopoietic cancers and butadiene and styrene exposure in synthetic rubber manufacture. Ann N Y Acad Sci 837:157-169, 1997.

94. Sorahan T, Parkes HG, Veys CA, Waterhouse JA, Straughan JK, Nutt A: Mortality in the British rubber industry 1946-85. Br J Ind Med 46:1-10, 1989.

95. Kogevinas M, Sala M, Boffetta P, Kazerouni N, Kromhout H, Hoar-Zahm S: Cancer risk in the rubber industry: a review of the recent epidemiological evidence. Occup Environ Med 55:1-12, 1998.

96. Sathiakumar N, Delzell E, Hovinga M, et al.: Mortality from cancer and other causes of death among synthetic rubber workers. Occup Environ Med 55:230-235, 1998.

97. Torres A, Giralt M, Raichs A: [Coexistence of chronic benzol contacts and multiple plasmacytoma. Presentation of 2 cases]. Sangre (Barc) 15:275-279, 1970.

98. Aksoy M: Malignancies due to occupational exposure to benzene. Haematologica 65:370-373, 1980.

99. Heineman EF, Olsen JH, Pottern LM, Gomez M, Raffn E, Blair A: Occupational risk factors for multiple myeloma among Danish men. Cancer Causes Control 3:555-568, 1992.

100. Pottern LM, Heineman EF, Olsen JH, Raffn E, Blair A: Multiple myeloma among Danish women: employment history and workplace exposures. Cancer Causes Control 3:427-432, 1992.

101. Bezabeh S, Engel A, Morris CB, Lamm SH: Does benzene cause multiple myeloma? An analysis of the published case-control literature. Environ Health Perspect 104(suppl 6):1393-1398, 1996.

102. Bergsagel DE, Wong O, Bergsagel PL, et al.: Benzene and multiple myeloma: appraisal of the scientific evidence. Blood 94:1174-1182, 1999.

103. Wong O, Raabe GK: Multiple myeloma and benzene exposure in a multinational cohort of more than 250,000 petroleum workers. Regul Toxicol Pharmacol 26:188-199, 1997.

104. Sonoda T, Nagata Y, Mori M, Ishida T, Imai K: Meta-analysis of multiple myeloma and benzene exposure. J Epidemiol 11:249-254, 2001.

105. Lee WJ, Baris D, Jarvholm B, Silverman DT, Bergdahl IA, Blair A: Multiple myeloma and diesel and other occupational exposures in Swedish construction workers. Int J Cancer 107:134-138, 2003.

106. Bukowski JA, Huebner WW, Schnatter AR, Wojcik NC: An analysis of the risk of B-lymphocyte malignancies in industrial cohorts. J Toxicol Environ Health A 66: 581-597, 2003.

107. Golden AL, Markowitz SB, Landrigan PJ: The risk of cancer in firefighters. Occup Med 10:803-820, 1995.

108. Eriksson M, Karlsson M: Occupational and other environmental factors and multiple myeloma: a population based case-control study. Br J Ind Med 49:95-103, 1992.

109. Nandakumar A, Armstrong BK, de Klerk NH: Multiple myeloma in Western Australia: a case-control study in relation to occupation, father's occupation, socioeconomic status and country of birth. Int J Cancer 37: 223-226, 1986.

110. Flodin U, Fredriksson M, Persson B: Multiple myeloma and engine exhausts, fresh wood, and creosote: a case-referent study. Am J Ind Med 12:519-529, 1987.

111. La Vecchia C, Negri E, D'Avanzo B, Franceschi S: Occupation and lymphoid neoplasms. Br J Cancer 60:385-388, 1989.

112. Demers PA, Boffetta P, Kogevinas M, et al.: Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries. Scand J Work Environ Health 21:179-190, 1995.

113. Fritschi L, Siemiatycki J: Lymphoma, myeloma and occupation: results of a case-control study. Int J Cancer 67:498-503, 1996.

114. Fu H, Demers PA, Costantini AS, et al.: Cancer mortality among shoe manufacturing workers: an analysis of two cohorts. Occup Environ Med 53:394-398, 1996.

115. Wartenberg D, Reyner D, Scott CS: Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect 108(suppl 2):161-176, 2000.

116. Costantini AS, Miligi L, Kriebel D, et al.: A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology 12:78-87, 2001.

117. Gallagher RP, Threlfall WJ: Cancer mortality in metal workers. Can Med Assoc J 129:1191-1194, 1983.

118. Morris PD, Koepsell TD, Daling JR, et al.: Toxic substance exposure and multiple myeloma: a case-control study. J Natl Cancer Inst 76:987-994, 1986.

119. McWhorter WP, Schatzkin AG, Horm JW, Brown CC: Contribution of socioeconomic status to black/white differences in cancer incidence. Cancer 63:982-987, 1989.

120. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J: Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Lancet 351:934-939, 1998.

121. Clayton LA, Byrd WM: The African-American cancer crisis. Part I: The problem. J Health Care Poor Underserved 4:83-101, 1993.

122. Vlajinac HD, Pekmezovic TD, Adanja BJ, et al.: case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 50:79-83, 2003.

123. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr: Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 15:35-43, 2004.

124. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625-1638, 2003.

125. Mills PK, Newell GR, Beeson WL, Fraser GE, Phillips RL: History of cigarette smoking and risk of leukemia and myeloma: results from the Adventist health study. J Natl Cancer Inst 82:1832-1836, 1990.

126. Heineman EF, Zahm SH, McLaughlin JK, Vaught JB, Hrubec Z: A prospective study of tobacco use and multiple myeloma: evidence against an association. Cancer Causes Control 3:31-36, 1992.

127. Brownson RC: Cigarette smoking and risk of myeloma. J Natl Cancer Inst 83:1036-1037, 1991.

128. Brown LM, Everett GD, Gibson R, Burmeister LF, Schuman LM, Blair A: Smoking and risk of non-Hodgkin's lymphoma and multiple myeloma. Cancer Causes Control 3:49-55, 1992.

129. Friedman GD: Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol 3:425-428, 1993.

130. Adami J, Nyren O, Bergstrom R, et al.: Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9:49-56, 1998.

131. Stagnaro E, Ramazzotti V, Crosignani P, et al.: Smoking and hematolymphopoietic malignancies. Cancer Causes Control 12:325-334, 2001.

132. Brown LM, Everett GD, Burmeister LF, Blair A: Hair dye use and multiple myeloma in white men. Am J Public Health 82:1673-1674, 1992.

133. Zahm SH, Weisenburger DD, Babbitt PA, Saal RC, Vaught JB, Blair A: Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia. Am J Public Health 82:990-997, 1992.

134. Herrinton LJ, Weiss NS, Koepsell TD, et al.: Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health 84:1142-1144, 1994.

135. Thun MJ, Altekruse SF, Namboodiri MM, Calle EE, Myers DG, Heath CW Jr: Hair dye use and risk of fatal cancers in U.S. women. J Natl Cancer Inst 86:210-215, 1994.

136. Colditz GA: Hair dye and cancer: reassuring evidence of no association. J Natl Cancer Inst 86:164-165, 1994.

137. Grodstein F, Hennekens CH, Colditz GA, Hunter DJ, Stampfer MJ: A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 86:1466-1470, 1994.

138. Altekruse SF, Henley SJ, Thun MJ: Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 10:617-625, 1999.

139. Hartge P: Hair dyes, cancer, and epidemiology. Cancer Invest 18:408, 2000.

140. Berlin SO, Odeberg H, Weingart L: Familial occurrence of M-components. Acta Med Scand 183:347-350, 1968.

141. Boga M, Jako J, Doman J, Magyar E, Konyar E: Familial myeloma. Folia Haematol Int Mag Klin Morphol Blutforsch 100:201-212, 1973.

142. Maldonado JE, Kyle RA: Familial myeloma. Report of eight families and a study of serum proteins in their relatives. Am J Med 57:875-884, 1974.

143. Law MI: Familial occurrence of multiple myeloma. South Med J 69:46-48, 1976.

144. Zawadzki ZA, Aizawa Y, Kraj MA, Haradin AR, Fisher B: Familial immunopathies: report of nine families and survey of literature. Cancer 40:2094-2101, 1977.

145. Youinou P, le Goff P, Saleun JP, et al.: Familial occurrence of monoclonal gammapathies. Biomedicine 28:226-232, 1978.

146. Deshpande HA, Hu XP, Marino P, Jan NA, Wiernik PH: Anticipation in familial plasma cell dyscrasias. Br J Haematol 103:696-703, 1998.

147. Shoenfeld Y, Berliner S, Shaklai M, Gallant LA, Pinkhas J: Familial multiple myeloma. A review of thirty-seven families. Postgrad Med J 58:12-16, 1982.

148. Bourguet CC, Grufferman S, Delzell E, DeLong ER, Cohen HJ: Multiple myeloma and family history of cancer. A case-control study. Cancer 56:2133-2139, 1985.

149. Loth TS, Perrotta AL, Lima J, Whiteaker RS, Robinson A: Genetic aspects of familial multiple myeloma. Mil Med 156:430-433, 1991.

150. Ogawa M, Wurster DH, McIntyre OR: Multiple myeloma in one of a pair of monozygotic twins. Acta Haematol 44:295-304, 1970.

151. Snowden JA, Greaves M: IgA lambda myeloma presenting concurrently in identical twins with subsequent transformation to 'aggressive phase' in one. Clin Lab Haematol 17:95-96, 1995.

152. Judson IR, Wiltshaw E, Newland AC: Multiple myeloma in a pair of monozygotic twins: the first reported case. Br J Haematol 60:551-554, 1985.

153. Hemminki K, Vaittinen P: National database of familial cancer in Sweden. Genet Epidemiol 15:225-236, 1998.

154. Brown LM, Linet MS, Greenberg RS, et al.: Multiple myeloma and family history of cancer among blacks and whites in the U.S. Cancer 85:2385-2390, 1999.

155. Grosbois B, Jego P, Attal M, et al.: Familial multiple myeloma: report of fifteen families. Br J Haematol 105:768-770, 1999.

156. Lynch HT, Sanger WG, Pirruccello S, Quinn-Laquer B, Weisenburger DD: Familial MM: a family study and review of the literature. J Natl Cancer Inst 93:1479-1483, 2001.

157. Hemminki K: Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 94:462-463, 2002; author reply: 463.

158. Sobol H, Vey N, Sauvan R, Philip N, Noguchi T, Eisinger F: Re: familial multiple myeloma: a family study and review of the literature. J Natl Cancer Inst 94:461-462, 2002; author reply: 463.

159. Nakayama S, Kitajima K, Ueno K, Hoshino T: [Multiple myeloma in spouses-with special reference to BHC as a possible cause (author's trans)]. Rinsho Ketsueki 21:73-79, 1980.

160. Lincz LF, Kerridge I, Scorgie FE, Bailey M, Enno A, Spencer A: Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89:628-629, 2004.

161. Davies FE, Dring AM, Li C, et al.: Insights into the multistep transformation of MGUS to myeloma using microar-ray expression analysis. Blood 102:4504-4511, 2003.

162. Munshi NC, Hideshima T, Carrasco D, et al.: Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood 103:1799-1806, 2004.

This page intentionally left blank

Was this article helpful?

0 0
Arthritis Relief Now

Arthritis Relief Now

When you hear the word arthritis, images of painful hands and joints comes into play. Few people fully understand arthritis and this guide is dedicated to anyone suffering with this chronic condition and wants relief now.

Get My Free Ebook

Post a comment